TKNO
Alpha Teknova, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$7.79
+4.56%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.06
- Revenue estimate
- $11.7M
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- -$0.06
- EPS estimate
- -$0.08
- Revenue actual
- $12.2M
- Revenue estimate
- $11.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +21.8%
- Revenue beats (12Q)
- 9
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $8.00
- PT range
- $7.00 – $9.00
- Analysts
- 3
3 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 5, 2026 | -$0.08 | -$0.06 | Beat 28.82% | $12.2M |
| May 6, 2026 | -$0.09 | -$0.08 | Beat 13.57% | $11.1M |
| Nov 6, 2025 | -$0.09 | -$0.08 | Beat 14.75% | $10.5M |
| Aug 7, 2025 | -$0.10 | -$0.07 | Beat 30.25% | $10.3M |
| May 8, 2025 | -$0.11 | -$0.09 | Beat 18.18% | $9.8M |
| Mar 4, 2025 | -$0.12 | -$0.11 | Beat 8.33% | $9.3M |
| Nov 7, 2024 | -$0.11 | -$0.15 | Miss -36.36% | $9.6M |
| Mar 11, 2024 | -$0.23 | -$0.22 | Beat 4.35% | $7.9M |
| Nov 9, 2023 | -$0.28 | -$0.34 | Miss -21.43% | $8.2M |
| Aug 10, 2023 | -$0.26 | -$0.25 | Beat 3.85% | $11.5M |
| Mar 15, 2023 | $0.34 | -$0.47 | Miss -238.24% | $7.9M |
| Nov 9, 2022 | -$0.29 | -$0.21 | Beat 27.59% | $10.7M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026